Improving anticoagulation therapy using point-of-care testing and a standardized protocol

Annals of Family Medicine

Volumn 6, Issue SUPPL. 1, 2008, Pages

  Franke, Curtis A ^a   Dickerson, Lori M ^b,c   Carek, Peter J ^b  

^a Health Texas Provider Network   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NONE   (United States)

Author keywords

Anticoagulation; Bedside testing; Dosing; International normalized ratio; Point of care systems; Primary care; Protocol; Venous thromboembolism; Warfarin

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DATA ANALYSIS; DEEP VEIN THROMBOSIS; DRUG MONITORING; FAMILY MEDICINE; FEMALE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PATIENT CARE; PATIENT MONITORING; POINT OF CARE TESTING; PRIMARY MEDICAL CARE; RESIDENT; STATISTICS; STUDENT T TEST; AGED; ALGORITHM; AMBULATORY CARE; CLINICAL PROTOCOL; DOSE RESPONSE; FIBRINOLYTIC THERAPY; HOSPITAL INFORMATION SYSTEM; METHODOLOGY; MIDDLE AGED; PRACTICE GUIDELINE; STANDARD; UNITED STATES;

ADULT; AGED; ALGORITHMS; AMBULATORY CARE; ANTICOAGULANTS; CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; OFFICE VISITS; POINT-OF-CARE SYSTEMS; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE; THROMBOLYTIC THERAPY; UNITED STATES; WARFARIN;

EID: 39049115242     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.739     Document Type: Article

References (28)

1. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I-4 to I-8.
2. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):204S-233S.
3. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):457S-482S.
4. Samsa GP, Matchar DB, Goldstein LB, et al. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med. 2000;160(7):967-973.
5. Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med. 2003;349(7):631-639.
6. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999;340(12):901-907.
7. Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med. 2001;345(3):165-169.
8. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. Arch Intern Med. 1996;156(4):409-416.
9. Shermock KM, Bragg L, Connor JT, Fink J, Mazzoli G, Kottke-Marchant K. Differences in warfarin dosing decisions based on international normalized ratio measurements with two point-of-care testing devices and a reference laboratory measurement. Pharmacotherapy. 2002;22(11):1397-1404.
10. Wurster M, Doran T. Anticoagulation management: a new approach. Dis Manag. 2006;9(4):201-209.
11. Poller L, Shiach CR, MacCallum PK, et al. Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation. Lancet. 1998;352(9139):1505-1509.
12. Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet. 2000;356(9224):97-102.
13. Cortelazzo S, Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost. 1993;69(4):316-320.
14. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158(15):1641-1647.
15. Ebell MH. Evidence-based initiation of warfarin (Coumadin). Am Fam Physician. 2005;71(4):763-765.
16. Wilson SJ, Wells PS, Kovacs MJ, et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ. 2003; 169(4):293-298.
17. Gill JM, Landis MK. Benefits of a mobile, point-of-care anticoagulation therapy management program. Jt Comm J Qual Improv. 2002;28(11):625-630.
18. Fitzmaurice DA, Murray ET, Gee KM, Allan TF, Hobbs FD. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol. 2002;55(11):845-849.
19. Gage BF. Pharmacogenetics-based coumarin therapy. Hematol Am Soc Hematol Educ Program. 2006(1):467-473.
20. Sunderji R, Gin K, Shalansky K, et al. Clinical impact of point-of-care vs laboratory measurement of anticoagulation. Am J Clin Pathol. 2005;123(2):184-188.
21. McBane RD 2nd, Felty CL, Hartgers ML, Chaudhry R, Beyer LK, Santrach PJ. Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs. Mayo Clin Proc. 2005;80(2):181-186.
22. Reiss RA, Haas CE, Griffis DL, Porter B, Tara MA. Point-of-care versus laboratory monitoring of patients receiving different anticoagulant therapies. Pharmacotherapy. 2002;22(6):677-685.
23. van den Besselaar AM. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis. 2001;12(1):35-40.
24. Jackson SL, Peterson GM, House M, Bartlett T. Point-of-care monitoring of anticoagulant therapy by rural community pharmacists: description of successful outcomes. Aust J Rural Health. 2004;12(5):197-200.
25. Jackson SL, Peterson GM, Vial JH, Jupe DM. Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation. J Intern Med. 2004;256(2):137-144.
26. Woods K, Douketis JD, Schnurr T, Kinnon K, Powers P, Crowther MA. Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thromb Res. 2004;114(3):161-165.
27. MacMillan D. Reimbursement for point of care testing. Point of Care. 2002;1(4):253-258.
28. Dalere GM, Coleman RW, Lum BL. A graphic nomogram for warfarin dosage adjustment. Pharmacotherapy. 1999;19(4):461-467.